• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾衰竭贫血:小鼠模型特征及人重组促红细胞生成素的纠正作用

Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin.

作者信息

Zhang F, Gagnon R F, Richards G K, Brox A G

机构信息

Department of Medicine, Montreal General Hospital, Que., Canada.

出版信息

Nephron. 1996;72(4):654-61. doi: 10.1159/000188955.

DOI:10.1159/000188955
PMID:8730437
Abstract

Anemia is a cardinal feature of chronic renal failure (CRF) which contributes significantly to the clinical syndrome of chronic uremia. We have conducted a detailed examination of the hematological changes in CRF in the inbred mouse strain C57BL/6J. As in the human situation, CRF mice presented major hematological changes affecting primarily the erythroid cell series. Despite the presence of abundant iron stores in the bone marrow, the CRF mice developed a hypoproliferative anemia of a severity commensurate with the degree of renal impairment. The levels of circulating erythropoietin (EPO) in CRF mice were not significantly different from those in normal control littermates and were therefore inappropriately low for the degree of anemia. In contrast acutely bled control mice with normal renal function showed a significant inverse correlation between the serum EPO level and hemoglobin concentration, indicating an appropriate response to anemia. The chronic administration of recombinant human EPO raised the hemoglobin concentration of CRF mice, a therapeutic effect which was independent of the initial degree of anemia. These observations suggest that this animal model has wide applicability for the study of anemia secondary to CRF.

摘要

贫血是慢性肾衰竭(CRF)的主要特征,对慢性尿毒症的临床综合征有显著影响。我们对近交系小鼠C57BL/6J慢性肾衰竭时的血液学变化进行了详细检查。与人类情况一样,慢性肾衰竭小鼠出现了主要影响红系细胞系的血液学变化。尽管骨髓中有丰富的铁储备,但慢性肾衰竭小鼠仍出现了增生低下性贫血,其严重程度与肾功能损害程度相当。慢性肾衰竭小鼠的循环促红细胞生成素(EPO)水平与正常对照同窝小鼠相比无显著差异,因此对于贫血程度而言其水平过低。相比之下,急性失血的肾功能正常的对照小鼠血清EPO水平与血红蛋白浓度呈显著负相关,表明对贫血有适当反应。长期给予重组人促红细胞生成素可提高慢性肾衰竭小鼠的血红蛋白浓度,这种治疗效果与初始贫血程度无关。这些观察结果表明,该动物模型在研究慢性肾衰竭继发性贫血方面具有广泛的适用性。

相似文献

1
Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin.慢性肾衰竭贫血:小鼠模型特征及人重组促红细胞生成素的纠正作用
Nephron. 1996;72(4):654-61. doi: 10.1159/000188955.
2
Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.用促红细胞生成素治疗与慢性肾衰竭相关的贫血:重组人红细胞生成素可能是现有选择中最好的。
Med Hypotheses. 2012 Jan;78(1):157-61. doi: 10.1016/j.mehy.2011.10.016. Epub 2011 Nov 10.
3
Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.重组人促红细胞生成素在治疗犬猫肾衰竭所致贫血中的应用。
J Am Vet Med Assoc. 1998 Feb 15;212(4):521-8.
4
Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse.
Kidney Int. 1996 Sep;50(3):937-43. doi: 10.1038/ki.1996.394.
5
[Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].促红细胞生成素-β治疗慢性肾功能不全患者贫血
Med Pregl. 2001 May-Jun;54(5-6):235-40.
6
Effect of chronic renal failure on the expression of erythropoietin message in a murine model.慢性肾衰竭对小鼠模型中促红细胞生成素信使表达的影响。
Exp Hematol. 1996 Nov;24(13):1469-74.
7
Management of renal anemia.肾性贫血的管理
Turk J Pediatr. 2005;47 Suppl:19-27.
8
Improvement of anemia associated with chronic renal failure by recombinant human erythropoietin treatment in ICR-derived glomerulonephritis (ICGN) mice.重组人促红细胞生成素治疗ICR衍生的肾小球肾炎(ICGN)小鼠改善慢性肾衰竭相关贫血
J Vet Med Sci. 2004 Jul;66(7):883-6. doi: 10.1292/jvms.66.883.
9
[Effects erythropoietin on experimental anemia in rats with chronic renal failure].[促红细胞生成素对慢性肾衰竭大鼠实验性贫血的影响]
Yao Xue Xue Bao. 1992;27(6):412-7.
10
[Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].[重组人促红细胞生成素治疗贫血及定期血液透析的尿毒症患者的骨髓反应]
Rev Clin Esp. 1990 May;186(9):419-22.

引用本文的文献

1
Mimicry of erythropoietin by a nonpeptide molecule.一种非肽分子对促红细胞生成素的模拟
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12156-61. doi: 10.1073/pnas.96.21.12156.